ALNYLAM PHARMACEUTICALS, INC. (ALNY) /
The revenue of ALNYLAM PHARMACEUTICALS, INC. over the past 10 years
Chart ALNYLAM PHARMACEUTICALS, INC.: revenue, fiscal 2016–2025 Open the chart →ALNYLAM PHARMACEUTICALS, INC. reported revenue of $3.71B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $47.16M — up 7775% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2019: up 193%, from $74.91M to $219.75M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $3.71B |
| 2024ended Dec 31, 2024 | $2.25B |
| 2023ended Dec 31, 2023 | $1.83B |
| 2022ended Dec 31, 2022 | $1.04B |
| 2021ended Dec 31, 2021 | $844.29M |
| 2020ended Dec 31, 2020 | $492.85M |
| 2019ended Dec 31, 2019 | $219.75M |
| 2018ended Dec 31, 2018 | $74.91M |
| 2017ended Dec 31, 2017 | $89.91M |
| 2016ended Dec 31, 2016 | $47.16M |
Fiscal years as ALNYLAM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ALNYLAM PHARMACEUTICALS, INC.
- The profitability of ALNYLAM PHARMACEUTICALS, INC.
- The cash flow of ALNYLAM PHARMACEUTICALS, INC.
- The debt of ALNYLAM PHARMACEUTICALS, INC.
- All of ALNYLAM PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTRSNORTHERN TRUST CORP
- WTWWILLIS TOWERS WATSON PLC
- RJFRAYMOND JAMES FINANCIAL, INC.
- MLMMARTIN MARIETTA MATERIALS INC
- HPQHP INC.
Not investment advice. This page shows what ALNYLAM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.